Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN News Highlights

Back to Item »

Phase IIIb Study Shows Benefits of Combining Onglyza with Insulin for Type 2 Diabetes

BMS and AstraZeneca say 52-week data showed dipeptidyl peptidase-4 (DPP-4) plus insulin therapy sustained reductions in HbA1c.

Forward this item to a colleague:
Your name
Your email
(Separate multiple addresses by commas)
 
Colleague's email
(Separate multiple addresses by commas)
 
Personal Message
(optional)
 
 
 

GEN Poll

More » Poll Results » Archive »

GEN’s Hall of Shame

Will you be voting for any of the candidates on GEN’s Hall of Shame list in the next election?

Suggest a Poll